A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate Efficacy
and Safety of Oral BT-11 in Mild to Moderate Ulcerative Colitis.

Register Today!

Trial Information

Trial Duration12 - 30 Weeks
Number of Visits9+ Visits
Lead CRCAlexus McCue
StatusUpcoming Trial

For additional information
on this trial contact:

Phone705-566-0005